⌕
Alpha Tau Medical · DRTS · Nasdaq
Tenet 40 · Weak
Compare
$11.97−10.54%At closeTenet 40 · Weak
$11.97−1.41 (−10.54%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Alpha Tau Medical (DRTS) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business enginePre-revenue: no positive revenue in any year through FY25, so the growth and margin read is withheld. Worth your attention in FY25: Share count (+21.1%) and Capex step-up ($6.1M). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)—
0.0
FY21→FY25CAGR —
Net income ($M)▼34.3%
−42.6
FY21→FY25CAGR —
Free cash flow ($M)▼48.7%
−32.8
capex stepped upCAGR —
Diluted EPS▼17.8%
−0.53
no value for 1 of 5 yearsCAGR —
What the receipts whisper · what a headline number hides
Share count
+21.1%

66.5mn → 80.6mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.

Capex step-up
$6.1M

▲171% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)0.0Revenue0.0COGS0.0Gross profit−32.1R&D−8.4SG&A−42.3Op income−0.3Tax & other−42.6Net income

Margin trend · direction beats level
108530%sector median net margin ~4%FY21FY25

This filer reports no gross profit or operating income line, so those margins are not drawn.

The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
Line itemFY25 †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
0.00.00.00.00.00.0——
Cost of revenue
0.00.00.00.00.00.0——
Gross profit
0.00.00.00.00.00.0——
Research & development
32,065.032,065.027,020.026,424.020,890.011,447.0▲18.7%+29.4%
Selling, general & admin
8,363.08,363.06,673.07,332.010,272.01,861.0▲25.3%+45.6%
Total operating expenses
42,288.042,288.036,042.035,680.032,136.013,790.0▲17.3%+32.3%
Operating incomefeeds ROC rank
−42,288.0−42,288.0−36,042.0−35,680.0−32,136.0−13,790.0▼17.3%—
Other income, net
−218.0−218.04,298.06,539.0−1,606.0−13,474.0——
Pretax income
−42,506.0−42,506.0−31,744.0−29,141.0−33,742.0−27,264.0▼33.9%—
Income tax
121.0121.06.016.020.07.0▲1916.7%+103.9%
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−42,627.0−42,627.0−31,750.0−29,157.0−33,762.0−27,271.0▼34.3%—
Per share
Diluted EPSbuyback-sensitive
−0.53−0.53−0.45−0.42−0.53—▼17.8%—
Diluted shares (mn)
80.5880.5869.9369.3863.5366.53▲15.2%+4.9%
Margins
† FY25 = fiscal 2025, through 2025-12-31; the trailing year is not available.
FY19 – FY20 · 2 more years
Unlock the full history →
2 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-03-09 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.